BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25005544)

  • 1. Engineered nanoparticles at the workplace: current knowledge about workers' risk.
    Pietroiusti A; Magrini A
    Occup Med (Lond); 2014 Jul; 64(5):319-30. PubMed ID: 25005544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational risk management of engineered nanoparticles.
    Schulte P; Geraci C; Zumwalde R; Hoover M; Kuempel E
    J Occup Environ Hyg; 2008 Apr; 5(4):239-49. PubMed ID: 18260001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing the key workplace challenge: assessing and preventing exposure to nanoparticles at source.
    Hämeri K; Lähde T; Hussein T; Koivisto J; Savolainen K
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():17-24. PubMed ID: 19558229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace exposure to engineered nanoparticles.
    Plitzko S
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():25-9. PubMed ID: 19558230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Special industrial medicine as a basis for workers' health preservation].
    Golovkova NP; Chebotarev AG; Leskina LM; Khelkovskiĭ-Sergeev NA; Ershov VP; Kotova NI; Koroleva EP; Makeeva LG; Pasekov AN
    Med Tr Prom Ekol; 2013; (6):25-9. PubMed ID: 23986948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat exposure in the Canadian workplace.
    Jay O; Kenny GP
    Am J Ind Med; 2010 Aug; 53(8):842-53. PubMed ID: 20623643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness and understanding of occupational exposure limits in Sweden.
    Schenk L
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):304-10. PubMed ID: 23376473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on occupational medical surveillance in employees handling nanoparticles.
    Nasterlack M; Zober A; Oberlinner C
    Int Arch Occup Environ Health; 2008 May; 81(6):721-6. PubMed ID: 17849141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study on occupational exposure limits of chemical substances in workplace between GBZ 2.1 in China and ACGIH in USA].
    Li W; Zhang M; Wang D
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Jan; 32(1):1-26. PubMed ID: 24428986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science.
    Schulte PA; Trout D; Zumwalde RD; Kuempel E; Geraci CL; Castranova V; Mundt DJ; Mundt KA; Halperin WE
    J Occup Environ Med; 2008 May; 50(5):517-26. PubMed ID: 18469620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice.
    Kuempel ED; Geraci CL; Schulte PA
    Ann Occup Hyg; 2012 Jul; 56(5):491-505. PubMed ID: 22752094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2011 Aug; 49(7):629-40. PubMed ID: 21861588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minority workers and communities.
    Frumkin H; Walker ED; Friedman-Jiménez G
    Occup Med; 1999; 14(3):495-517. PubMed ID: 10378973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sharpening the focus on occupational safety and health in nanotechnology.
    Schulte P; Geraci C; Zumwalde R; Hoover M; Castranova V; Kuempel E; Murashov V; Vainio H; Savolainen K
    Scand J Work Environ Health; 2008 Dec; 34(6):471-8. PubMed ID: 19137209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On methods for unambiguous assessment of occupational environmental factors in occupational medicine].
    Krasovskiĭ VO; Aminova GG
    Med Tr Prom Ekol; 2004; (1):22-7. PubMed ID: 15029672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occupational risk for agricultural workers health, hygienic aspects of its assessment and management (literature review)].
    Novikova TA; Spirin VF; Mikhaĭlova NA; Taranova VM
    Med Tr Prom Ekol; 2012; (5):22-8. PubMed ID: 22855995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle usage and protection measures in the manufacturing industry--a representative survey.
    Schmid K; Danuser B; Riediker M
    J Occup Environ Hyg; 2010 Apr; 7(4):224-32. PubMed ID: 20155559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knowledge of selected occupational groups about biological agents in the environment and ways of health protection against occupational exposure to biological hazards].
    Zielińska-Jankiewicz K; Kozajda A
    Med Pr; 2003; 54(5):399-406. PubMed ID: 14978888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure assessment of carbon nanotube manufacturing workplaces.
    Lee JH; Lee SB; Bae GN; Jeon KS; Yoon JU; Ji JH; Sung JH; Lee BG; Lee JH; Yang JS; Kim HY; Kang CS; Yu IJ
    Inhal Toxicol; 2010 Apr; 22(5):369-81. PubMed ID: 20121582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to nanomedical applications.
    Murashov V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):203-13. PubMed ID: 20049791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.